A Healthy Lifestyle Will Help Patients Get Through Myeloma Treatment

Video

It is essential for patients to live a healthy lifestyle while undergoing treatment for multiple myeloma, an expert said.

When undergoing treatment for multiple myeloma, it is essential that patients take up healthy habits to mitigate or control other health conditions and be able to tolerate potential side effects of the cancer treatment, explained Dr. Krina K. Patel.

READ MORE: How a Nutritious Diet May Help During Myeloma Treatment

In a recent interview at the 2023 European Hematology Association Congress, Patel, who is an associate professor in the Department of Lymphoma/Myeloma, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, Texas, emphasized the importance of healthy lifestyle for individuals undergoing myeloma treatment. And, with many clinical trials having eligibility criteria based onhow healthy a patient is overall and how independently they can perform their daily tasks, this is particularly important for patients hoping to participate in the research of new drugs and therapies, according to Patel.

Transcription

I tell my patients that … even though we're talking about myeloma all the time, I want your heart and your brain and your kidneys to be really good, too. So it's really important to do everything you can to stay as healthy as possible.

You know, we want your quality of life to be good, but to do that, you still have to be healthy. So really, it's about your performance status and other comorbidities … Any treatment I want to give you, I want to make sure I'm not going to make things worse for you, right? So especially those patients who are in early-line induction therapy, and now just went through either transplant or on maintenance (therapy, which aims to prevent disease from coming back), that's the time to really start working on getting in shape and changing lifestyle habits so that we can actually get you through these other therapies. They are overall safe. But you know, nothing has zero toxicity.

So, I will say the majority of my patients are eligible for these trials. But again, it's really making sure it's the right thing at the right time for you, and that we've optimized the rest of your body and mind to get you through this so that you can enjoy that quality of life after.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE